Laboratory of Zoology and General Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco.
National Reference Laboratory of Leishmaniasis, National Institute of Hygiene, Rabat, Morocco.
Biomed Res Int. 2019 Aug 8;2019:5327287. doi: 10.1155/2019/5327287. eCollection 2019.
In Morocco, species is the main causative agents of visceral leishmaniasis (VL). However, cutaneous leishmaniasis (CL) due to has been reported sporadically. Moreover, the recent geographical expansion of in the Mediterranean subregion leads us to suggest whether the nonsporadic cases of CL due to this species are present. In this context, this review is written to establish a retrospective study of cutaneous and visceral leishmaniasis in northern Morocco between 1997 and 2018 and also to conduct a molecular study to identify the circulating species responsible for the recent cases of leishmaniases in this region. Data concerning leishmaniases cases were collected from the Epidemiology and Disease Control Directorate from 1997 to 2018. Human samples obtained from peripheral laboratories were examined using PCR-ITS1 method. The ITS1 products were subjected to digestion with the restriction endonuclease Mn1-I. Between 1997 and 2018, a total of 1,255 cases of cutaneous and visceral leishmaniasis were recorded in Tangier-Tetouan-Al Hoceima Region, i.e., 1.56% of the reported cases in Morocco (1,255/80,299). Concerning the geographical study covering the period 2007-2018, 79.5% (105/132) of the sectors were affected by leishmaniases. The molecular results showed that Humans were found to be infected with the species with a high infection rate compared to infection. Moreover, molecular characterization using ITS1 PCR-RFLP showed that the density of was significantly higher (n = 68/81; 84%) than that of (n = 13/81; 16%) (-value 9.894e-10). While regarding visceral leishmaniasis, was the only species responsible of this form. These findings of this study showed the emergence of in Morocco and suggest that this species might be more prevalent than previously thought. Furthermore, the molecular determination of will be helpful for control strategies by taking into consideration the reservoir of this species.
在摩洛哥, 是内脏利什曼病(VL)的主要病原体。然而,已零星报告了由 引起的皮肤利什曼病(CL)。此外,最近 在地中海次区域的地理扩张使我们怀疑是否存在由该物种引起的非偶发性 CL 病例。在这种情况下,撰写了这篇综述,以建立 1997 年至 2018 年摩洛哥北部皮肤利什曼病和内脏利什曼病的回顾性研究,并进行分子研究以确定该地区最近利什曼病病例的循环物种。从 1997 年至 2018 年,从流行病学和疾病控制局收集了有关利什曼病病例的数据。从周边实验室获得的人类样本使用 PCR-ITS1 方法进行检查。ITS1 产物用限制性内切酶 Mn1-I 进行消化。1997 年至 2018 年间,在丹吉尔-特图安-胡塞马地区共记录了 1255 例皮肤利什曼病和内脏利什曼病,即摩洛哥报告病例的 1.56%(1255/80299)。关于涵盖 2007-2018 年期间的地理研究,79.5%(105/132)的扇区受到利什曼病的影响。分子结果表明,与 感染相比,人类被发现感染 物种的感染率较高。此外,使用 ITS1 PCR-RFLP 的分子特征表明, 的密度明显更高(n=68/81;84%),而 的密度(n=13/81;16%)(-值 9.894e-10)。而关于内脏利什曼病, 是唯一负责该形式的物种。本研究的这些发现表明 已在摩洛哥出现,并表明该物种的流行率可能高于先前的预期。此外,对 的分子鉴定将有助于控制策略,考虑到该物种的储库。